Colorectal Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan Kettering's current clinical trials for colorectal cancer.

Showing 28 trials
Title Investigator
A Phase I Study of ADI-PEG 20 plus FOLFOX in Patients with Advanced Digestive Cancers
[Protocol 14-153]
Harding, James, MD
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen, MD
A Phase I Study of CB-839 in Patients with Advanced Solid Tumors
[Protocol 14-111]
Harding, James, MD
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David, MD
A Phase I Study of High-Dose-Rate Brachytherapy plus Chemotherapy in Patients with Recurrent Rectal or Anal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-104]
Goodman, Karyn, MD
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil, MD, PhD
A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors
[Protocol 11-052]
Hyman, David, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil, MD, PhD
A Phase I Study of TAS-102 plus CPT-11 (Irinotecan) in Patients with Advanced Digestive Cancers
[Protocol 13-105]
Saltz, Leonard, MD
A Phase IB Study of INC280 plus Cetuximab in Patients with Recurrent or Metastatic Colorectal or Head and Neck Cancer
[Protocol 14-173]
Fury, Matthew, MD, PhD
A Phase IB Study of Urelumab (BMS-663513) plus Cetuximab in Patients with Persistent Head and Neck or Colorectal Cancer
[Protocol 14-121]
Segal, Neil, MD, PhD
A Phase Ib/II Study of LGX818 and Cetuximab with or without BYL719 in Patients with BRAF-Mutant Metastatic Colorectal Cancer
[Protocol 14-019]
Yaeger, Rona, MD
A Phase Ib/II Study of MEK162 plus Panitumumab in Patients with Metastatic Colorectal Cancer
[Protocol 14-044]
Yaeger, Rona, MD
A Phase II Study of Chemotherapy and Chemoradiation Followed by Surgery or Non-Operative Management in Patients with Stage II or III Rectal Cancer
[Protocol 13-213]
Garcia-Aguilar, Julio, MD, PhD
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy, MD
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David, MD
A Phase III Study of Dapsone Gel versus Moisturizer (Placebo) to Treat Cetuximab-Related Rash
[Protocol 13-012]
Lacouture, Mario, MD
A Study Comparing the Effectiveness of Virtual and Standard Colonoscopy for Colorectal Cancer Follow-up
[Protocol 13-103]
Gollub, Marc, MD
A Study of a Neuromodulation Device for Patients with Bowel Dysfunction after Rectal Cancer Surgery
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-100]
Temple, Larissa, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients
[Protocol 04-144]
Stadler, Zsofia, MD
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087]
Saltz, Leonard, MD
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth, MD
Coping with Cancer II
[Protocol 14-048]
Epstein, Andrew, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia, MD
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome
[Protocol 09-122]
Sofocleous, Constantinos, MD, PhD
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110]
Guillem, Jose, MD
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Phase II Study of Early Post-Operative Abdominal Chemotherapy versus Heated Abdominal Chemotherapy for Cancers of the Appendix, Colon, or Rectum that Have Spread to the Abdominal Lining
[Protocol 12-289]
Nash, Garrett, MD